← All verdicts
Verdict

Valuation N/A

Every analyzed stock in Valuation N/A — 479 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Valuation N/A" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
TWLVR
Twelve Seas Investment Co III/Cayman
Valuation N/A
Financial Services
Price$0.09
Model IV—
P/IV—
Limited data — see page
TWN
TAIWAN FUND INC
Valuation N/A
Unknown
Price$103.15
Model IV—
P/IV—
Limited data — see page
TY
TRI-CONTINENTAL Corp
Valuation N/A
Unknown
Price$34.58
Model IV—
P/IV—
Limited data — see page
TYG
TORTOISE ENERGY INFRASTRUCTURE CORP
Valuation N/A
Unknown
Price$44.12
Model IV—
P/IV—
Limited data — see page
TYRA
Tyra Biosciences, Inc.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$22.03
Model IV—
P/IV—
Limited data — see page
UAC
United Acquisition Corp. I
Valuation N/A
Financial Services
Price$9.97
Model IV—
P/IV—
Limited data — see page
UBS
UBS Group AG
Valuation N/A
Financial Services Risk 59 · Elevated
Price$54.58
Model IV—
P/IV—
Limited data — see page
UCFI
CN Healthy Food Tech Group Corp.
Valuation N/A
Consumer Defensive Risk 38 · Moderate
Price$5.51
Model IV—
P/IV—
Limited data — see page
UFG
Uni-Fuels Holdings Ltd
Valuation N/A
Consumer Defensive Risk 33 · Moderate
Price$0.57
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
UGLD
UGLD
Valuation N/A
Risk 33 · Moderate
Price$21.99
Model IV—
P/IV—
Limited data — see page
UMC
UNITED MICROELECTRONICS CORP
Valuation N/A
Technology Risk 42 · Elevated
Price$21.90
Model IV—
P/IV—
Market implies +53.4%/yr vs model +3.0% · above model
UROY
UROY
Valuation N/A
Risk 42 · Elevated
Price$4.36
Model IV—
P/IV—
Limited data — see page
USA
LIBERTY ALL STAR EQUITY FUND
Valuation N/A
Unknown
Price$5.88
Model IV—
P/IV—
Limited data — see page
USAS
Americas Gold & Silver Corp
Valuation N/A
Basic Materials Risk 37 · Moderate
Price$4.69
Model IV—
P/IV—
Market implies +39.6%/yr vs model +27.2% · above model
USLV
USLV
Valuation N/A
Risk 40 · Elevated
Price$15.76
Model IV—
P/IV—
Limited data — see page
USML
UBS AG
Valuation N/A
Financial Services Risk 33 · Moderate
Price$47.26
Model IV—
P/IV—
Limited data — see page
UTF
COHEN & STEERS INFRASTRUCTURE FUND INC
Valuation N/A
Unknown
Price$25.93
Model IV—
P/IV—
Limited data — see page
UTG
REAVES UTILITY INCOME FUND
Valuation N/A
Unknown
Price$37.86
Model IV—
P/IV—
Limited data — see page
UUP
UUP
Valuation N/A
Risk 36 · Moderate
Price$28.07
Model IV—
P/IV—
Limited data — see page
UVIX
VS Trust
Valuation N/A
Financial Services Risk 32 · Moderate
Price$39.16
Model IV—
P/IV—
Limited data — see page
UYSC
UY Scuti Acquisition Corp.
Valuation N/A
Financial Services Risk 31 · Moderate
Price$11.00
Model IV—
P/IV—
Limited data — see page
UYSCR
UY Scuti Acquisition Corp.
Valuation N/A
Financial Services Risk 33 · Moderate
Price$0.10
Model IV—
P/IV—
Limited data — see page
UZD
ARRAY DIGITAL INFRASTRUCTURE, INC.
Valuation N/A
Communication Services Risk 44 · Elevated
Price$18.51
Model IV—
P/IV—
Market implies -19.4%/yr vs model +25.0% · below model
UZE
ARRAY DIGITAL INFRASTRUCTURE, INC.
Valuation N/A
Communication Services Risk 44 · Elevated
Price$16.30
Model IV—
P/IV—
Market implies -21.5%/yr vs model +25.0% · below model
UZF
ARRAY DIGITAL INFRASTRUCTURE, INC.
Valuation N/A
Communication Services Risk 55 · Elevated
Price$16.27
Model IV—
P/IV—
Market implies -21.5%/yr vs model +25.0% · below model
VACH
VACH
Valuation N/A
Risk 39 · Moderate
Price$17.11
Model IV—
P/IV—
Limited data — see page
VACI
Viking Acquisition Corp I
Valuation N/A
Communication Services
Price$6.88
Model IV—
P/IV—
Limited data — see page
VALE
Vale S.A.
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$14.47
Model IV—
P/IV—
Limited data — see page
VALN
Valneva SE
Valuation N/A
Healthcare Risk 51 · Elevated
Price$6.66
Model IV—
P/IV—
Limited data — see page
VANI
Vivani Medical, Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$1.27
Model IV—
P/IV—
Limited data — see page
VBF
Invesco Bond Fund
Valuation N/A
Unknown
Price$14.48
Model IV—
P/IV—
Limited data — see page
VBNK
VersaBank
Valuation N/A
Financial Services Risk 52 · Elevated
Price$22.62
Model IV—
P/IV—
Limited data — see page
VCV
Invesco California Value Municipal Income Trust
Valuation N/A
Unknown
Price$9.93
Model IV—
P/IV—
Limited data — see page
VCX
Fundrise Innovation Fund, LLC
Valuation N/A
Unknown
Price$33.50
Model IV—
P/IV—
Limited data — see page
VECA
Vernal Capital Acquisition Corp.
Valuation N/A
Financial Services Risk 32 · Moderate
Price$10.02
Model IV—
P/IV—
Limited data — see page
VERA
Vera Therapeutics, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$35.05
Model IV—
P/IV—
Limited data — see page
VET
VERMILION ENERGY INC.
Valuation N/A
Energy Risk 32 · Moderate
Price$13.23
Model IV—
P/IV—
Limited data — see page
VFL
VFL
Valuation N/A
Price$11.31
Model IV—
P/IV—
Limited data — see page
VGI
Virtus Global Multi-Sector Income Fund
Valuation N/A
Unknown
Price$7.18
Model IV—
P/IV—
Limited data — see page
VGM
Invesco Trust for Investment Grade Municipals
Valuation N/A
Unknown
Price$9.85
Model IV—
P/IV—
Limited data — see page
VGNT
Versigent PLC
Valuation N/A
Consumer Cyclical Risk 58 · Elevated
Price$45.19
Model IV—
P/IV—
Limited data — see page
VHCP
Vine Hill Capital Investment Corp. II
Valuation N/A
Financial Services
Price$10.07
Model IV—
P/IV—
Limited data — see page
VIDA
VIDA Global Inc.
Valuation N/A
Technology Risk 36 · Moderate
Price$2.13
Model IV—
P/IV—
Limited data — see page
VIK
Viking Holdings Ltd
Valuation N/A
Industrials
Price$86.42
Model IV—
P/IV—
Limited data — see page
VINP
Vinci Compass Investments Ltd.
Valuation N/A
Financial Services
Price$9.44
Model IV—
P/IV—
Limited data — see page
VIV
TELEFONICA BRASIL S.A.
Valuation N/A
Communication Services Risk 33 · Moderate
Price$11.85
Model IV—
P/IV—
Limited data — see page
VIVO
VivoPower PLC
Valuation N/A
Utilities Risk 26 · Moderate
Price$3.99
Model IV—
P/IV—
Limited data — see page
VKI
Invesco Advantage Municipal Income Trust II
Valuation N/A
Unknown
Price$8.54
Model IV—
P/IV—
Limited data — see page
VKQ
Invesco Municipal Trust
Valuation N/A
Unknown
Price$9.39
Model IV—
P/IV—
Limited data — see page
VKTX
Viking Therapeutics, Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$31.98
Model IV—
P/IV—
Limited data — see page
VLRS
Controladora Vuela Compania de Aviacion, S.A.B. de C.V.
Valuation N/A
Industrials
Price$6.52
Model IV—
P/IV—
Limited data — see page
VLT
Invesco High Income Trust II
Valuation N/A
Unknown
Price$9.69
Model IV—
P/IV—
Limited data — see page
VMAR
Vision Marine Technologies Inc.
Valuation N/A
Consumer Cyclical Risk 28 · Moderate
Price$7.65
Model IV—
P/IV—
Market implies -26.6%/yr vs model +50.0% · below model
VMO
Invesco Municipal Opportunity Trust
Valuation N/A
Unknown
Price$9.38
Model IV—
P/IV—
Limited data — see page
VNET
VNET Group, Inc.
Valuation N/A
Technology Risk 39 · Moderate
Price$6.33
Model IV—
P/IV—
Limited data — see page
VNME
Vendome Acquisition Corp I
Valuation N/A
Financial Services
Price$10.27
Model IV—
P/IV—
Limited data — see page
VOC
VOC Energy Trust
Valuation N/A
Energy
Price$3.36
Model IV—
P/IV—
Limited data — see page
VOD
VODAFONE GROUP PUBLIC LTD CO
Valuation N/A
Communication Services Risk 55 · Elevated
Price$17.40
Model IV—
P/IV—
Limited data — see page
VOR
Vor Biopharma Inc.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$22.30
Model IV—
P/IV—
Limited data — see page
VOXR
VOX ROYALTY CORP.
Valuation N/A
Basic Materials Risk 37 · Moderate
Price$5.79
Model IV—
P/IV—
Market implies +36.4%/yr vs model +34.8% · in line